Recursion Pharmaceuticals Earnings Call Shows Efficient Progress

Detailed price information for Recursion Pharmaceuticals Inc Cl A (RXRX-Q) from The Globe and Mail including charting and trades.
MIT Technology Review

The Download: AI’s self-improvement problem, and what’s driving the heat

Find out why the results may temper claims that recursive self-improvement is on the horizon. —Michelle Kim This summer has ...

The Zacks Analyst Blog Highlights Recursion Pharmaceuticals, Schrodinger, Relay Therapeutics and Absci

Detailed price information for Relay Therapeutics Inc (RLAY-Q) from The Globe and Mail including charting and trades.

Contineum, Disc Medicine, Recursion Advance Pipelines Ahead of Catalysts, Morgan Stanley Says

Disc Medicine (IRON), and Recursion Pharmaceuticals (RXRX) are making meaningful pipeline progress, with key clinical and regulatory catalysts ahead in 2026, Morgan Stanley said in a note Monday.
Zacks Investment Research on MSN

4 AI-powered drug discovery stocks to watch as AI reshapes pharma

Artificial intelligence (AI) is poised to reshape pharmaceutical research by addressing some of the industry's most ...